Diabetes mellitus and the life-threatening late complications of cardivascular disease

November 14, 2012, Medical University of Vienna
Diabetes mellitus and the life-threatening late complications of cardivascular disease

Between 600,000 and 800,000 Austrians have diabetes mellitus. This "sugar disease", as it is known, can itself already be treated very effectively. The later consequences of diabetes, however, which mostly affect the blood vessels and cause cardiovascular conditions such as myocardial infarctions or strokes, are more likely to be fatal. Diabetes expert Michael Resl from the University Department of Internal Medicine III at the MedUni Vienna, on the occasion of World Diabetes Day on 14th November, is keen to draw people's attention to this threat.

Cardiovascular diseases are the most common cause of death in patients with diabetes mellitus. The blood vessels of patients with are 15 years "older" than those of people who do not have the condition. And: the risk of suffering a heart attack is also just as high as people who have already had one. On average, a diagnosis of diabetes mellitus means a reduction in life expectancy of seven to eight years.
 
At the MedUni Vienna and in the Vienna General Hospital, there is a close, between the departments of diabetology, cardiology and ophthalmology which ensures that patients are given the best possible interdisciplinary care. As well as projects that have been running for a long time, which have produced numerous publications in high-ranking journals, the recently initiated Vidinet cooperation (Vienna Diabetes Network) is also intended to further optimise interdisciplinary treatment pathways and the collaboration between the individual departments.

Says Resl: "We have biomarkers which we can use to better estimate the increased in patients with diabetes mellitus and therefore treat it at an earlier stage." As well as the protein output in the urine (proteinuria), NT-proBNP, a hormone produced by the heart, is an excellent tool for estimating the risk of developing cardiovascular disease.  

Taking treatment seriously lifelong

Willingness on the part of the patient to actively participate in their treatment – and to do so lifelong – is very important: "They need to understand the risks to their health, take them seriously and make lifestyle changes that continue for the rest of their lives." Modern treatment is multifactorial and includes lowering blood sugar levels, reducing blood pressure, treating raised cholesterol levels and reducing obesity through healthier eating.  

Explore further: One cause of fatty deposits in the hearts of diabetes patients settled

Related Stories

One cause of fatty deposits in the hearts of diabetes patients settled

April 16, 2012
The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, Austrian researchers at the ...

Psoriasis patients at high risk of diabetes

August 27, 2012
Patients with psoriasis are at high risk of new-onset diabetes mellitus, according to research presented at ESC Congress 2012. The findings were presented at the press conference by Dr Ole Ahlehoff from Copenhagen University ...

Diabetes associated with higher risk of cardiovascular problems in men

March 25, 2012
According to a new study by researchers at Brigham and Women's Hospital (BWH), men with type 2 diabetes treated with insulin without a history of cardiovascular disease (CVD) were at higher risk for major cardiovascular events ...

Serious complications in people with type 1 diabetes and ongoing poor blood sugar control

October 2, 2012
Strategies implemented in high-income countries to improve blood glucose control in people with type 1 diabetes and so reduce complications, such as heart attacks, strokes, and early death, are working, but there is much ...

Concern over intensive treatment for patients with type 2 diabetes

July 26, 2011
Doctors should be cautious about prescribing intensive glucose lowering treatment for patients with type 2 diabetes as a way of reducing heart complications, concludes a new study published in the British Medical Journal ...

Recommended for you

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

Gene therapy restores normal blood glucose levels in mice with type 1 diabetes

January 4, 2018
Type 1 diabetes is a chronic disease in which the immune system attacks and destroys insulin-producing beta cells in the pancreas, resulting in high blood levels of glucose. A study published January 4th in Cell Stem Cell ...

Goodbye, needles? Patch might be the future for blood-sugar tracking

January 4, 2018
(HealthDay)—Developers of a new patch hope to eliminate a big barrier in type 2 diabetes treatment—painful finger-sticks and injections. The new patch—which actually uses an array of tiny needles that researchers promise ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.